 |
N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2006-03-24 00:00:00 |
| Sponsor | Pfizer, Inc.;50 Pequot Avenue, 6025-A3106;New London, Connecticut, 06320 |
Related Access Program